… Several cases of unusual thrombotic events and thrombocytopenia have developed after …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (ChAdOx1 nCov-19, AstraZeneca). …

… We report findings in five patients who presented with venous thrombosis and … dose of
the ChAdOx1 nCoV-19 adenoviral vector vaccine against coronavirus disease 2019 (Covid-19). …

… received at least one dose of either the ChAdOx1 or BNT162b2 vaccine. The large study …
of the ChAdOx1 vaccine and cerebral venous thromboses, and venous thromboses at other …

… thrombocytopenia and multiple thromboses after she received the ChAdOx1 nCoV-19 vaccine.
… the second week after she received the ChAdOx1 nCoV-19 vaccine. Extensive diagnostic …

… for thrombotic events were higher at younger ages for venous thromboses after ChAdOx1-S,
and for arterial thromboses … effects of first COVID-19 vaccination on major thrombotic events. …

… million second doses of the ChAdOx1 vaccine 17 . Three … thrombotic events after ChAdOx1
vaccination, which clinically mimics heparin-induced thrombocytopenia 11,12,13 . ChAdOx1’…

… Paired 1-way ANOVA followed by Dunn's multiple … 50 μL ChAdOx1 nCoV-19 in wild-type
mice. Segments give relative percentage in multiple organs of disseminated ChAdOx1 nCoV-19 …

… potentially distinct thrombotic syndrome associated with ChAdOx1-S.… , arterial thrombosis,
and venous thrombosis in unusual … covid-19 vaccination strategies, the majority of ChAdOx1-S …

… with thrombosis and thrombocytopaenia 10–16 days following the first dose of the ChAdOx1
nCoV-19 vaccine … All three patients presented with extensive venous thrombosis, significant …

… Here we report two cases of malignant middle cerebral artery (MCA) infarct and
thrombocytopenia 9-10 days following ChAdOx1 nCoV-19 vaccination. The two cases arrived in our …